2m 2m 2m 2m 2m 2m 2m
ENVVENO MEDICAL (NVNO)
NASDAQ
$10.68-$0.07 (-0.70%)
Price as of Jun 03, 2026 6:02 PM EDT- $7.6MMarket Cap
- -91.15%1-Year Change
- Medical DevicesIndustry
ENVVENO MEDICAL (NVNO)
$10.68-$0.07 (-0.70%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 735,000 -55.18% | 1.6M +6.36% | 1.5M +857.76% | 161,000 +760.55% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 735,000 -55.18% | 1.6M +6.36% | 1.5M +857.76% | 161,000 +760.55% | |
Sales and Marketing Expense | 10.9M -5.69% | 11.6M -0.67% | 11.7M -22.39% | 15.0M +34.51% | |
Research and Development Expense | -10.0M -18.52% | -12.2M -9.82% | -13.6M +37.01% | -9.9M +73.09% | |
Depreciation and Amortization Expense | 136,000 -28.04% | 189,000 -14.09% | 220,000 +3.77% | 212,000 +42.28% | |
Total Operating Expenses | 10.9M -5.69% | 11.6M -0.67% | 11.7M -22.39% | 15.0M +34.51% | |
Operating Profit | -20.9M -12.28% | -23.8M -5.59% | -25.2M +1.23% | -24.9M +47.59% | |
Interest Income | 692,000 +77.89% | 389,000 +116.11% | 180,000 +267.35% | 49,000 N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 692,000 +77.89% | 389,000 +116.11% | 180,000 +267.35% | 49,000 N/A | |
Total Nonoperating Income and Expense | 1.4M -28.90% | 2.0M +16.55% | 1.7M +554.75% | 263,000 -27.88% | |
Income before Taxes | -20.9M -12.28% | -23.8M -5.59% | -25.2M +1.23% | -24.9M +50.85% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | -21.8M -7.22% | -23.5M -4.67% | -24.7M +49.26% | |
Net Income from Continuing Operations Applicable to Common | -19.5M -10.76% | -21.8M -7.22% | -23.5M -4.67% | -24.7M +49.26% | |
Basic EPS and Net Income | -33.06 +2,503.15% | -1.27 -33.51% | -1.91 -13.18% | -2.20 +15.79% | |
Diluted EPS and Net Income | -33.06 +2,503.15% | -1.27 -33.51% | -1.91 -13.18% | -2.20 +15.79% | |
Basic Weighted Average Shares | 589,000 -96.56% | 17.1M +39.35% | 12.3M +9.54% | 11.2M +29.38% | |
Diluted Weighted Average Shares | 589,000 -96.56% | 17.1M +39.35% | 12.3M +9.54% | 11.2M +29.38% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.1M +74.74% | 1.8M -51.55% | 3.6M -20.53% | 4.6M -91.68% | |
Short-Term Investments | 25.1M -39.26% | 41.4M -3.26% | 42.8M +24.07% | 34.5M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 28.2M -34.62% | 43.2M -7.02% | 46.4M +18.87% | 39.0M -28.66% | |
Total Current Assets | 28.8M -34.09% | 43.7M -6.80% | 46.9M +18.99% | 39.4M -28.35% | |
Accumulated Depreciation | 1.4M +10.82% | 1.3M +17.59% | 1.1M +25.91% | 849,000 +33.30% | |
Property and Plant and Equipment and Net | 51,000 -71.98% | 182,000 -45.51% | 334,000 -35.89% | 521,000 -15.68% | |
Total Long-Term Assets | 51,000 -71.98% | 182,000 -45.51% | 334,000 -35.89% | 521,000 -15.68% | |
Total Assets | 29.6M -34.24% | 45.0M -7.57% | 48.6M +16.74% | 41.7M -27.80% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 568,000 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 300,000 -4.06% | |
Total Current Liabilities | 2.1M +1.29% | 2.1M +52.81% | 1.4M -10.39% | 1.5M -3.17% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 310,000 -55.71% | 700,000 -34.21% | 1.1M -24.11% | 1.4M -18.24% | |
Total Liabilities | 2.4M -12.99% | 2.8M +14.78% | 2.4M -16.95% | 2.9M -11.01% | |
Retained Earnings | -171.3M +12.82% | -151.9M +16.78% | -130.0M +22.08% | -106.5M +30.14% | |
Total Stockholders Equity | N/A N/A | 42.2M -8.75% | 46.2M +19.29% | 38.7M -28.81% | |
Total Shares Outstanding | 655,606 -96.26% | 17.5M +31.68% | 13.3M +40.59% | 9.5M +0.02% | |
Cash Flow | |||||
Cash from Operating Activities | -15.6M -7.54% | -16.8M -10.71% | -18.9M +20.74% | -15.6M +31.85% | |
Capital Expenditures | 5,000 -86.49% | 37,000 +12.12% | 33,000 -71.30% | 115,000 -68.74% | |
Cash from Investing Activities | 15.9M +1,087.72% | 1.3M +116.97% | -7.9M -77.23% | -34.6M +9,292.48% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.0M -92.50% | 13.6M -47.12% | 25.8M N/A | N/A N/A | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -2,843.40% +95.72% | -1,452.80% -11.24% | -1,636.71% -89.43% | -15,485.71% -82.85% | |
Return on Assets | N/A N/A | -46.63% -10.48% | -52.09% +4.90% | -49.66% +2.50% | |
Return on Equity | N/A N/A | -49.39% -10.82% | -55.38% +4.53% | -52.98% -1.44% | |
Revenue Growth | -55.18% -968.28% | 6.36% -99.26% | 857.76% +12.78% | 760.55% +26.68% | |
Current Ratio | 13.58 -34.93% | 20.88 -39.01% | 34.23 +32.78% | 25.78 -26.01% | |
Cash Ratio | 1.44 +72.53% | 0.84 -68.29% | 2.64 -11.31% | 2.98 -91.40% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow